Sexual dimorphism in ischemic stroke: Lessons from the laboratory

Women's Health

Volumn 7, Issue 3, 2011, Pages 319-339

  Manwani, Bharti ^a,b   McCullough, Louise D ^a,b  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b HARTFORD HOSPITAL   (United States)

Author keywords

blood brain barrier; caspase; estrogen; estrogen receptor ; histone deacetylase; middle cerebral artery occlusion; ovariectomy; poly ADP ribose polymerase; sex differences; Sry; testosterone

Indexed keywords

C REACTIVE PROTEIN; CASPASE; CONJUGATED ESTROGEN; CYTOCHROME C; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; MINOCYCLINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEURONAL NITRIC OXIDE SYNTHASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NITRIC OXIDE; PLACEBO; PLASMINOGEN ACTIVATOR INHIBITOR 1; TESTOSTERONE; TISSUE PLASMINOGEN ACTIVATOR;

AGING; BLOOD CLOT LYSIS; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; DISEASE MODEL; DRUG DOSE COMPARISON; ECLAMPSIA; EPIGENETICS; FIBRINOLYTIC THERAPY; HIPPOCAMPAL CA1 REGION; HORMONE SUBSTITUTION; HUMAN; INCIDENCE; INFLAMMATION; MECHANICAL THROMBECTOMY; MIDDLE CEREBRAL ARTERY OCCLUSION; MORTALITY; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PROGNOSIS; RECURRENCE RISK; REVIEW; SECONDARY PREVENTION; SEX DIFFERENCE; SOCIAL SUPPORT; SURVIVAL RATE; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK; X CHROMOSOME;

AGING; ANIMALS; BRAIN; BRAIN ISCHEMIA; EPIGENESIS, GENETIC; FEMALE; FIBRINOLYTIC AGENTS; HORMONES; HUMANS; MALE; MICE; POSTMENOPAUSE; SEX FACTORS; STROKE;

EID: 79957552463     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/whe.11.22     Document Type: Review

References (220)

1. Lloyd-Jones D, Adams RJ, Brown TM et al.: Heart disease and stroke statistics - 2010 update: a report from the american heart association. Circulation 121(7), e46-e215 (2010).
2. Sudlow CL, Warlow CP: Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. Stroke 28(3), 491-499 (1997).
3. Lai SM, Duncan PW, Dew P, Keighley J: Sex differences in stroke recovery. Prev. Chronic Dis. 2(3), A13 (2005).
4. Mack WJ, Slater CC, Xiang M, Shoupe D, Lobo RA, Hodis HN: Elevated subclinical atherosclerosis associated with oophorectomy is related to time since menopause rather than type of menopause. Fertil. Steril. 82(2), 391-397 (2004).
5. Lisabeth LD, Beiser AS, Brown DL, Murabito JM, Kelly-Hayes M, Wolf PA: Age at natural menopause and risk of ischemic stroke: the Framingham heart study. Stroke 40(4), 1044-1049 (2009).
6. Suzuki SC, Brown M, Wise PM: Neuroprotective effects of estrogens following ischemic stroke. Front. Neuroendocrinol. 30(2), 201-211 (2009).
7. Turtzo LC, McCullough LD: Sex-specific responses to stroke. Future Neurol. 5(1), 47-59 (2010).
8. Bushnell CD: Oestrogen and stroke in women: assessment of risk. Lancet Neurol. 4(11), 743-751 (2005).
9. Petrea RE, Beiser AS, Seshadri S, Kelly-Hayes M, Kase CS, Wolf PA: Gender differences in stroke incidence and poststroke disability in the Framingham heart study. Stroke 40(4), 1032-1037 (2009).
10. Rothwell PM, Coull AJ, Silver LE et al.: Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (oxford vascular study). Lancet 366(9499), 1773-1783 (2005).
11. Roger VL, Go AS, Lloyd-Jones DM et al.: Heart disease and stroke statistics - 2011 update: a report from the American Heart Association. Circulation 123(4), e18-e209 (2011). 2011 stroke update.
12. Towfighi A, Saver JL, Engelhardt R, Ovbiagele B: A midlife stroke surge among women in the United States. Neurology 69(20), 1898-1904 (2007).
13. Kittner SJ, Stern BJ, Feeser BR et al.: Pregnancy and the risk of stroke. N. Engl. J. Med. 335(11), 768-774 (1996).
14. Sharshar T, Lamy C, Mas JL: Incidence and causes of strokes associated with pregnancy and puerperium. A study in public hospitals of ile de france. Stroke in pregnancy study group. Stroke 26(6), 930-936 (1995).
15. Feigin VL, Barker-Collo S, Parag V et al.: Auckland stroke outcomes study. Part 1: gender. Stroke types, ethnicity, and functional outcomes 5 years poststroke. Neurology 75(18), 1597-1607 (2010).
16. Knauft W, Chhabra J, McCullough LD: Emergency department arrival times, treatment, and functional recovery in women with acute ischemic stroke. J. Womens Health (Larchmt.) 19(4), 681-688 (2010).
17. Roquer J, Campello AR, Gomis M: Sex differences in first-ever acute stroke. Stroke 34(7), 1581-1585 (2003).
18. Kapral MK, Fang J, Hill MD, Silver F, Richards J, Jaigobin C, Cheung AM: Sex differences in stroke care and outcomes: results from the Registry of the Canadian Stroke Network. Stroke 36(4), 809-814 (2005).
19. Silva GS, Lima FO, Camargo EC et al.: Gender differences in outcomes after ischemic stroke: role of ischemic lesion volume and intracranial large-artery occlusion. Cerebrovasc. Dis. 30(5), 470-475 (2010).
20. Boden-Albala B, Litwak E, Elkind MS, Rundek T, Sacco RL: Social isolation and outcomes post stroke. Neurology 64(11), 1888-1892 (2005).
21. Reeves M, Bhatt A, Jajou P, Brown M, Lisabeth L: Sex differences in the use of intravenous rt-PA thrombolysis treatment for acute ischemic stroke: a meta-analysis. Stroke 40(5), 1743-1749 (2009).
22. Foerch C, Misselwitz B, Humpich M, Steinmetz H, Neumann-Haefelin T, Sitzer M: Sex disparity in the access of elderly patients to acute stroke care. Stroke 38(7), 2123-2126 (2007).
23. Allen NB, Myers D, Watanabe E et al.: Utilization of intravenous tissue plasminogen activator for ischemic stroke: are there sex differences? Cerebrovasc. Dis. 27(3), 254-258 (2009).
24. Reed SD, Cramer SC, Blough DK, Meyer K, Jarvik JG: Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals. Stroke 32(8), 1832-1840 (2001).
25. Reid JM, Dai D, Gubitz GJ, Kapral MK, Christian C, Phillips SJ: Gender differences in stroke examined in a 10-year cohort of patients admitted to a canadian teaching hospital. Stroke 39(4), 1090-1095 (2008).
26. Lutsep HL, Hill MD: Effects of sex on mechanical embolectomy outcome. J. Stroke Cerebrovasc. Dis. (2011) (Epub ahead of print).
27. Arnold M, Fischer U, Compter AJ et al.: Acute basilar artery occlusion in the basilar artery international cooperation study: does gender matter? Stroke 41(11), 2693-2696 (2010).
28. Smith MA, Lisabeth LD, Brown DL, Morgenstern LB: Gender comparisons of diagnostic evaluation for ischemic stroke patients. Neurology 65(6), 855-858 (2005).
29. Kapral MK, Ben-Yakov M, Fang J et al.: Gender differences in carotid imaging and revascularization following stroke. Neurology 73(23), 1969-1974 (2009).
30. Lichtman JH, Naert L, Allen NB et al.: Use of antithrombotic medications among elderly ischemic stroke patients. Circ. Cardiovasc. Qual. Outcomes. 4(1), 30-38 (2011).
31. Gall SL, Donnan G, Dewey HM et al.: Sex differences in presentation, severity, and management of stroke in a population-based study. Neurology 74(12), 975-981 (2010).
32. Labiche LA, Chan W, Saldin KR, Morgenstern LB: Sex and acute stroke presentation. Ann. Emerg. Med. 40(5), 453-460 (2002).
33. Barrett KM, Brott TG, Brown RD Jr et al.: Sex differences in stroke severity, symptoms, and deficits after first-ever ischemic stroke. J. Stroke Cerebrovasc. Dis. 16(1), 34-39 (2007).
34. Gargano JW, Wehner S, Reeves MJ: Do presenting symptoms explain sex differences in emergency department delays among patients with acute stroke? Stroke 40(4), 1114-1120 (2009).
35. Stuart-Shor EM, Wellenius GA, DelloIacono DM, Mittleman MA: Gender differences in presenting and prodromal stroke symptoms. Stroke 40(4), 1121-1126 (2009).
36. Dearborn JL, McCullough LD: Perception of risk and knowledge of risk factors in women at high risk for stroke. Stroke 40(4), 1181-1186 (2009).
37. Rexrode KM, Emerging risk factors in women. Stroke 41(Suppl. 10), S9-S11 (2010).
38. Kent DM, Price LL, Ringleb P, Hill MD, Selker HP: Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke: a pooled analysis of randomized clinical trials. Stroke 36(1), 62-65 (2005).
39. Hill MD, Kent DM, Hinchey J et al.: Sex-based differences in the effect of intra-arterial treatment of stroke: analysis of the PROACT-2 study. Stroke 37(9), 2322-2325 (2006).
40. Shobha N, Sylaja PN, Kapral MK, Fang J, Hill MD: Differences in stroke outcome based on sex. Neurology 74 (9), 767-771 (2010).
41. Savitz SI, Schlaug G, Caplan L, Selim M: Arterial occlusive lesions recanalize more frequently in women than in men after intravenous tissue plasminogen activator administration for acute stroke. Stroke 36(7), 1447-1451 (2005).
42. Roeloffzen WW, Kluin-Nelemans HC, Mulder AB et al.: In normal controls, both age and gender affect coagulability as measured by thrombelastography. Anesth. Analg. 110(4), 987-994 (2010).
43. Koh KK, Mincemoyer R, Bui MN et al.: Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women. N. Engl. J. Med. 336(10), 683-690 (1997).
44. Kim SH, Han SW, Kim EH et al.: Plasma fibrinolysis inhibitor levels in acute stroke patients with thrombolysis failure. J. Clin. Neurol. 1(2), 142-147 (2005).
45. Kawase K, Okazaki S, Toyoda K et al.: Sex difference in the prevalence of deep-vein thrombosis in Japanese patients with acute intracerebral hemorrhage. Cerebrovasc. Dis. 27(4), 313-319 (2009).
46. Kyrle PA, Minar E, Bialonczyk C, Hirschl M, Weltermann A, Eichinger S: The risk of recurrent venous thromboembolism in men and women. N. Engl. J. Med. 350(25), 2558-2563 (2004).
47. Jarvis CR, Anderson TR, Andrew RD: Anoxic depolarization mediates acute damage independent of glutamate in neocortical brain slices. Cereb. Cortex 11(3), 249-259 (2001).
48. Wise-Faberowski L, Robinson PN, Rich S, Warner DS: Oxygen and glucose deprivation in an organotypic hippocampal slice model of the developing rat brain: the effects on N-methyl-D-aspartate subunit composition. Anesth. Analg. 109(1), 205-210 (2009).
49. Li H, Pin S, Zeng Z, Wang MM, Andreasson KA, McCullough LD: Sex differences in cell death. Ann. Neurol. 58(2), 317-321 (2005).
50. Du L, Bayir H, Lai Y et al.: Innate gender-based proclivity in response to cytotoxicity and programmed cell death pathway. J. Biol. Chem. 279(37), 38563-38570 (2004).
51. Liu M, Dziennis S, Hurn PD, Alkayed NJ: Mechanisms of gender-linked ischemic brain injury. Restor. Neurol. Neurosci. 27(3), 163-179 (2009).
52. Guo J, Krause DN, Horne J, Weiss JH, Li X, Duckles SP: Estrogen-receptor-mediated protection of cerebral endothelial cell viability and mitochondrial function after ischemic insult in vitro. J. Cereb. Blood Flow Metab. 30(3), 545-554 (2010).
53. Fordyce CB, Jagasia R, Zhu X, Schlichter LC: Microglia kv1.3 channels contribute to their ability to kill neurons. J. Neurosci. 25(31), 7139-7149 (2005).
54. Xie Z, Wei M, Morgan TE et al.: Peroxynitrite mediates neurotoxicity of amyloid β-peptide1-42- and lipopolysaccharide-activated microglia. J. Neurosci. 22(9), 3484-3492 (2002).
55. Kaushal V, Schlichter LC: Mechanisms of microglia-mediated neurotoxicity in a new model of the stroke penumbra. J. Neurosci. 28(9), 2221-2230 (2008).
56. Richard MJ, Saleh TM, El Bahh B, Zidichouski JA: A novel method for inducing focal ischemia in vitro. J. Neurosci. Methods 190(1), 20-27 (2010).
57. Graham SM, McCullough LD, Murphy SJ: Animal models of ischemic stroke: balancing experimental aims and animal care. Comp. Med. 54(5), 486-496 (2004).
58. Durukan A, Tatlisumak T: Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol. Biochem. Behav. 87(1), 179-197 (2007). Review on experimental models of stroke.
59. Hall ED, Traystman RJ: Role of animal studies in the design of clinical trials. Front. Neurol. Neurosci. 25, 10-33 (2009).
60. Howells DW, Porritt MJ, Rewell SS et al.: Different strokes for different folks: the rich diversity of animal models of focal cerebral ischemia. J. Cereb. Blood Flow Metab. 30(8), 1412-1431 (2010).
61. Ng YS, Stein J, Ning M, Black-Schaffer RM: Comparison of clinical characteristics and functional outcomes of ischemic stroke in different vascular territories. Stroke 38(8), 2309-2314 (2007).
62. Plump AS, Smith JD, Hayek T et al.: Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in es cells. Cell 71(2), 343-353 (1992).
63. Nabika T, Cui Z, Masuda J: The stroke-prone spontaneously hypertensive rat: how good is it as a model for cerebrovascular diseases? Cell Mol. Neurobiol. 24(5), 639-646 (2004).
64. Vannucci SJ, Willing LB, Goto S et al.: Experimental stroke in the female diabetic, db/db, mouse. J. Cereb. Blood Flow Metab. 21(1), 52-60 (2001).
65. Golomb MR, Fullerton HJ, Nowak-Gottl U, Deveber G: Male predominance in childhood ischemic stroke: findings from the international pediatric stroke study. Stroke 40(1), 52-57 (2009).
66. Fullerton HJ, Wu YW, Zhao S, Johnston SC: Risk of stroke in children: ethnic and gender disparities. Neurology 61(2), 189-194 (2003).
67. Lang JT, McCullough LD: Pathways to ischemic neuronal cell death: are sex differences relevant? J. Transl. Med. 6, 33 (2008). Review on sex differences in cell death mechanisms in stroke.
68. Lieb K, Andrae J, Reisert I, Pilgrim C: Neurotoxicity of dopamine and protective effects of the nmda receptor antagonist ap-5 differ between male and female dopaminergic neurons. Exp. Neurol. 134(2), 222-229 (1995).
69. Zhang L, Li PP, Feng X, Barker JL, Smith SV, Rubinow DR: Sex-related differences in neuronal cell survival and signaling in rats. Neurosci. Lett. 337(2), 65-68 (2003).
70. Liu M, Hurn PD, Roselli CE, Alkayed NJ: Role of p450 aromatase in sex-specific astrocytic cell death. J. Cereb. Blood Flow Metab. 27(1), 135-141 (2007).
71. Siegel C, Turtzo C, McCullough LD: Sex differences in cerebral ischemia: possible molecular mechanisms. J. Neurosci. Res. 88(13), 2765-2774 (2010).
72. Carswell HV, Dominiczak AF, Macrae IM: Estrogen status affects sensitivity to focal cerebral ischemia in stroke-prone spontaneously hypertensive rats. Am. J. Physiol. Heart Circ. Physiol. 278(1), H290-H294 (2000).
73. Alkayed NJ, Harukuni I, Kimes AS, London ED, Traystman RJ, Hurn PD: Gender-linked brain injury in experimental stroke. Stroke 29(1), 159-165; discussion 166 (1998). Reported neuroprotective effects of estrogen in stroke.
74. Yamori Y, Horie R, Handa H, Sato M, Fukase M: Pathogenetic similarity of strokes in stroke-prone spontaneously hypertensive rats and humans. Stroke 7(1), 46-53 (1976).
75. Zhang L, Nair A, Krady K et al.: Estrogen stimulates microglia and brain recovery from hypoxia-ischemia in normoglycemic but not diabetic female mice. J. Clin. Invest. 113(1), 85-95 (2004).
76. Hurn PD, Vannucci SJ, Hagberg H: Adult or perinatal brain injury: does sex matter? Stroke 36(2), 193-195 (2005).
77. DiNapoli VA, Huber JD, Houser K, Li X, Rosen CL: Early disruptions of the blood-brain barrier may contribute to exacerbated neuronal damage and prolonged functional recovery following stroke in aged rats. Neurobiol. Aging 29(5), 753-764 (2008).
78. Liu F, Yuan R, Benashski SE, McCullough LD: Changes in experimental stroke outcome across the life span. J. Cereb. Blood Flow Metab. 29(4), 792-802 (2009). Reported stroke outcomes in aging female mice.
79. Wang RY, Wang PS, Yang YR: Effect of age in rats following middle cerebral artery occlusion. Gerontology 49(1), 27-32 (2003).
80. Alkayed NJ, Murphy SJ, Traystman RJ, Hurn PD, Miller VM: Neuroprotective effects of female gonadal steroids in reproductively senescent female rats. Stroke 31(1), 161-168 (2000).
81. Rusa R, Alkayed NJ, Crain BJ et al.: 17β-estradiol reduces stroke injury in estrogen-deficient female animals. Stroke 30(8), 1665-1670 (1999).
82. Bake S, Sohrabji F: 17β-estradiol differentially regulates blood-brain barrier permeability in young and aging female rats. Endocrinology 145(12), 5471-5475 (2004).
83. Shapira S, Sapir M, Wengier A, Grauer E, Kadar T: Aging has a complex effect on a rat model of ischemic stroke. Brain Res. 925(2), 148-158 (2002).
84. Feigin VL, Lawes CM, Bennett DA, Anderson CS: Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol. 2(1), 43-53 (2003).
85. Mouton PR, Long JM, Lei DL et al.: Age and gender effects on microglia and astrocyte numbers in brains of mice. Brain Res. 956(1), 30-35 (2002).
86. Lucin KM, Wyss-Coray T: Immune activation in brain aging and neurodegeneration: too much or too little? Neuron 64(1), 110-122 (2009).
87. Jurgens HA, Johnson RW: Dysregulated neuronal-microglial cross-talk during aging, stress and inflammation. Exp. Neurol. (2010) (Epub ahead of print).
88. Badan I, Buchhold B, Hamm A et al.: Accelerated glial reactivity to stroke in aged rats correlates with reduced functional recovery. J. Cereb. Blood Flow Metab. 23(7), 845-854 (2003).
89. Li J, Siegel M, Yuan M et al.: Estrogen enhances neurogenesis and behavioral recovery after stroke. J. Cereb. Blood Flow Metab. 31(2), 413-425 (2011).
90. Love S, Barber R, Wilcock GK: Neuronal death in brain infarcts in man. Neuropathol. Appl. Neurobiol. 26(1), 55-66 (2000).
91. Ferrer I, Planas AM: Signaling of cell death and cell survival following focal cerebral ischemia: life and death struggle in the penumbra. J. Neuropathol. Exp. Neurol. 62(4), 329-339 (2003).
92. Sattler R, Tymianski M: Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death. Mol. Neurobiol. 24(1-3), 107-129 (2001).
93. Stout AK, Raphael HM, Kanterewicz BI, Klann E, Reynolds IJ: Glutamate-induced neuron death requires mitochondrial calcium uptake. Nat. Neurosci. 1(5), 366-373 (1998).
94. Castilho RF, Hansson O, Ward MW, Budd SL, Nicholls DG: Mitochondrial control of acute glutamate excitotoxicity in cultured cerebellar granule cells. J. Neurosci. 18(24), 10277-10286 (1998).
95. Dawson VL, Dawson TM, London ED, Bredt DS, Snyder SH: Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl Acad. Sci. USA 88(14), 6368-6371 (1991).
96. Beckman JS, Crow JP: Pathological implications of nitric oxide, superoxide and peroxynitrite formation. Biochem. Soc. Trans. 21(2), 330-334 (1993).
97. Crow JP, Beckman JS: Reactions between nitric oxide, superoxide, and peroxynitrite: Footprints of peroxynitrite in vivo. Adv. Pharmacol. 34, 17-43 (1995).
98. Endres M, Scott G, Namura S et al.: Role of peroxynitrite and neuronal nitric oxide synthase in the activation of poly(ADP-ribose) synthetase in a murine model of cerebral ischemia-reperfusion. Neurosci. Lett. 248(1), 41-44 (1998).
99. Endres M, Wang ZQ, Namura S, Waeber C, Moskowitz MA: Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase. J. Cereb. Blood Flow Metab. 17(11), 1143-1151 (1997).
100. Du L, Zhang X, Han YY et al.: Intra-mitochondrial poly(ADP-ribosylation) contributes to NAD+ depletion and cell death induced by oxidative stress. J. Biol. Chem. 278(20), 18426-18433 (2003).
101. Yu SW, Wang H, Dawson TM, Dawson VL: Poly(ADP-ribose) polymerase-1 and apoptosis inducing factor in neurotoxicity. Neurobiol. Dis. 14(3), 303-317 (2003).
102. Yu SW, Wang H, Poitras MF et al.: Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 297(5579), 259-263 (2002).
103. Plesnila N, Zhu C, Culmsee C, Groger M, Moskowitz MA, Blomgren K: Nuclear translocation of apoptosis-inducing factor after focal cerebral ischemia. J. Cereb. Blood Flow Metab. 24(4), 458-466 (2004).
104. McCullough LD, Zeng Z, Blizzard KK, Debchoudhury I, Hurn PD: Ischemic nitric oxide and poly (ADP-ribose) polymerase-1 in cerebral ischemia: male toxicity, female protection. J. Cereb. Blood Flow Metab. 25(4), 502-512 (2005).
105. Alano CC, Kauppinen TM, Valls AV, Swanson RA: Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations. Proc. Natl Acad. Sci. USA 103(25), 9685-9690 (2006).
106. Lampl Y, Boaz M, Gilad R et al.: Minocycline treatment in acute stroke: an open-label, evaluator-blinded study. Neurology 69(14), 1404-1410 (2007).
107. Orsucci D, Calsolaro V, Mancuso M, Siciliano G: Neuroprotective effects of tetracyclines: molecular targets, animal models and human disease. CNS Neurol. Disord. Drug Targets 8(3), 222-231 (2009).
108. Li J, McCullough LD: Sex differences in minocycline-induced neuroprotection after experimental stroke. J. Cereb. Blood Flow Metab. 29(4), 670-674 (2009).
109. Liu F, Li Z, Li J, Siegel C, Yuan R, McCullough LD: Sex differences in caspase activation after stroke. Stroke 40(5), 1842-1848 (2009).
110. Renolleau S, Fau S, Goyenvalle C L et al.: Specific caspase inhibitor Q-VD-Oph prevents neonatal stroke in p7 rat: a role for gender. J. Neurochem. 100(4), 1062-1071 (2007).
111. Kuida K, Haydar TF, Kuan CY et al.: Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 94(3), 325-337 (1998).
112. Li P, Nijhawan D, Budihardjo I et al.: Cytochrome c and datp-dependent formation of apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91(4), 479-489 (1997).
113. Yoshida H, Kong YY, R. Yoshida et al.: APAF1 is required for mitochondrial pathways of apoptosis and brain development. Cell 94(6), 739-750 (1998).
114. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X: APAF-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90(3), 405-413 (1997).
115. Sugawara T, Fujimura M, Noshita N et al.: Neuronal death/survival signaling pathways in cerebral ischemia. NeuroRx 1(1), 17-25 (2004).
116. Zou H, Li Y, Liu X, Wang X: An APAF-1. cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem. 274(17), 11549-11556 (1999).
117. Jiang X, Wang X: Cytochrome c promotes caspase-9 activation by inducing nucleotide binding to APAF-1. J. Biol. Chem. 275(40), 31199-31203 (2000).
118. Du L, Hickey RW, Bayir H et al.: Starving neurons show sex difference in autophagy. J. Biol. Chem. 284(4), 2383-2396 (2009).
119. Arnold AP: The organizational-activational hypothesis as the foundation for a unified theory of sexual differentiation of all mammalian tissues. Horm. Behav. 55(5), 570-578 (2009). Organizational activational effects of hormones.
120. Cohen-Bendahan CC, van de Beek C, Berenbaum SA: Prenatal sex hormone effects on child and adult sex-typed behavior: methods and findings. Neurosci. Biobehav. Rev. 29(2), 353-384 (2005).
121. Arnold AP: The organizational-activational hypothesis as the foundation for a unified theory of sexual differentiation of all mammalian tissues. Horm. Behav. 55(5), 570-578 (2009).
122. Clemens LG, Gladue BA: Feminine sexual behavior in rats enhanced by prenatal inhibition of androgen aromatization. Horm. Behav. 11(2), 190-201 (1978).
123. Bakker J, De Mees C, Douhard Q et al.: α-fetoprotein protects the developing female mouse brain from masculinization and defeminization by estrogens. Nat. Neurosci. 9(2), 220-226 (2006).
124. Woolley CS, McEwen BS: Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J. Comp. Neurol. 336(2), 293-306 (1993).
125. Leranth C, Petnehazy O, MacLusky NJ: Gonadal hormones affect spine synaptic density in the ca1 hippocampal subfield of male rats. J. Neurosci. 23(5), 1588-1592 (2003).
126. Hurn PD, Macrae IM: Estrogen as a neuroprotectant in stroke. J. Cereb. Blood Flow Metab. 20(4), 631-652 (2000).
127. Dubal DB, Kashon ML, Pettigrew LC et al.: Estradiol protects against ischemic injury. J. Cereb. Blood Flow Metab. 18(11), 1253-1258 (1998).
128. Simpkins JW, Rajakumar G, Zhang YQ et al.: Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat. J. Neurosurg. 87(5), 724-730 (1997).
129. McCullough LD, Hurn PD: Estrogen and ischemic neuroprotection: an integrated view. Trends Endocrinol. Metab. 14(5), 228-235 (2003).
130. Dubal DB, Zhu H, Yu J et al.: Estrogen receptor α, not β, is a critical link in estradiol-mediated protection against brain injury. Proc. Natl Acad. Sci. USA 98(4), 1952-1957 (2001).
131. Bruce-Keller AJ, Keeling JL, Keller JN et al.: Antiinflammatory effects of estrogen on microglial activation. Endocrinology 141(10), 3646-3656 (2000).
132. Drew PD, Chavis JA: Female sex steroids: effects upon microglial cell activation. J. Neuroimmunol. 111(1-2), 77-85 (2000).
133. Johnson AB, Sohrabji F: Estrogen's effects on central and circulating immune cells vary with reproductive age. Neurobiol. Aging 26(10), 1365-1374 (2005).
134. Tapia-Gonzalez S, Carrero P, Pernia O, Garcia-Segura LM, Diz-Chaves Y: Selective oestrogen receptor (ER) modulators reduce microglia reactivity in vivo after peripheral inflammation: potential role of microglialers, J. Endocrinol. 198(1), 219-230 (2008).
135. Vegeto E, Bonincontro C, Pollio G et al.: Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia. J. Neurosci. 21(6), 1809-1818 (2001).
136. Merlo S, Calafiore M, Vancheri C, Luigi Canonico P, Copani A, Sortino MA: Astrocyte-like cells as a main target for estrogen action during neuronal differentiation. Mol. Cell. Neurosci. 34(4), 562-570 (2007).
137. Azcoitia I, Sierra A, Garcia-Segura LM: Localization of estrogen receptor β-immunoreactivity in astrocytes of the adult rat brain. Glia 26(3), 260-267 (1999).
138. Azcoitia I, Sierra A, Veiga S, Garcia-Segura LM: Aromatase expression by reactive astroglia is neuroprotective. Ann. NY Acad. Sci. 1007, 298-305 (2003).
139. Naftolin F: Brain aromatization of androgens. J. Reprod. Med. 39(4), 257-261 (1994).
140. McCullough LD, Blizzard K, Simpson ER, Oz OK, Hurn PD: Aromatase cytochrome p450 and extragonadal estrogen play a role in ischemic neuroprotection. J. Neurosci. 23(25), 8701-8705 (2003).
141. Galea LA: Gonadal hormone modulation of neurogenesis in the dentate gyrus of adult male and female rodents. Brain Res. Rev. 57(2), 332-341 (2008).
142. Perez-Martin M, Azcoitia I, Trejo JL, Sierra A, Garcia-Segura LM: An antagonist of estrogen receptors blocks the induction of adult neurogenesis by insulin-like growth factor-I in the dentate gyrus of adult female rat. Eur. J. Neurosci. 18(4), 923-930 (2003).
143. Wassertheil-Smoller S, Hendrix SL, Limacher M et al.: Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA 289(20), 2673-2684 (2003). Women's Health Initiative (WHI) clinical trial.
144. Viscoli CM, Brass LM, Kernan WN et al.: Estrogen therapy and risk of cognitive decline: results from the Women's Estrogen for Stroke Trial (WEST). Am. J. Obstet. Gynecol. 192(2), 387-393 (2005).
145. Shumaker SA, Legault C, Rapp SR et al.: Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289(20), 2651-2662 (2003).
146. Viscoli CM, Brass LM, Kernan WN, Sarrel PM, Suissa S, Horwitz RI: A clinical trial of estrogen-replacement therapy after ischemic stroke. N. Engl. J. Med. 345(17), 1243-1249 (2001).
147. Carswell HV, Macrae IM, Farr TD: Complexities of oestrogen in stroke. Clin. Sci. (Lond.) 118(6), 375-389 (2010).
148. Wilson ME, Dubal DB, Wise PM: Estradiol protects against injury-induced cell death in cortical explant cultures: a role for estrogen receptors. Brain Res. 873(2), 235-242 (2000).
149. Chambliss KL, Shaul PW: Estrogen modulation of endothelial nitric oxide synthase. Endocr. Rev. 23(5), 665-686 (2002).
150. Prestwood KM, Kenny AM, Kleppinger A, Kulldorff M: Ultralow-dose micronized 17β-estradiol and bone density and bone metabolism in older women: a randomized controlled trial. JAMA 290(8), 1042-1048 (2003).
151. Lakoski SG, Herrington DM: Effects of hormone therapy on c-reactive protein and IL-6 in postmenopausal women: a review article. Climacteric 8(4), 317-326 (2005).
152. Wong JH, Dukes J, Levy RE et al.: Sex differences in thrombosis in mice are mediated by sex-specific growth hormone secretion patterns. J. Clin. Invest. 118(8), 2969-2978 (2008).
153. Suzuki S, Brown CM, Dela Cruz CD, Yang E, Bridwell DA, Wise PM: Timing of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and antiinflammatory actions. Proc. Natl Acad. Sci. USA 104(14), 6013-6018 (2007).
154. Appt SE, Clarkson TB, Lees CJ, Anthony MS: Low dose estrogens inhibit coronary artery atherosclerosis in postmenopausal monkeys. Maturitas 55(2), 187-194 (2006).
155. Teede HJ: Hormone replacement therapy and the prevention of cardiovascular disease. Hum. Reprod. Update 8(3), 201-215 (2002).
156. Harman SM, Brinton EA, Cedars M et al.: Santoro, KEEPS: the KRONOS early estrogen prevention study. Climacteric 8(1), 3-12 (2005). The Kronos Early Estrogen Prevention Study (KEEPS).
157. Cheng J, Alkayed NJ, Hurn PD: Deleterious effects of dihydrotestosterone on cerebral ischemic injury. J. Cereb. Blood Flow Metab. 27(9), 1553-1562 (2007).
158. Normann S, de Veber G, Fobker M et al.: Role of endogenous testosterone concentration in pediatric stroke. Ann. Neurol. 66(6), 754-758 (2009).
159. Vannucci SJ, Hurn PD: Gender differences in pediatric stroke: is elevated testosterone a risk factor for boys? Ann. Neurol. 66(6), 713-714 (2009).
160. Cheng J, Hu W, Toung TJ et al.: Age-dependent effects of testosterone in experimental stroke. J. Cereb. Blood Flow Metab. 29(3), 486-494 (2009).
161. Hawk T, Zhang YQ, Rajakumar G, Day AL, Simpkins JW: Testosterone increases and estradiol decreases middle cerebral artery occlusion lesion size in male rats. Brain Res. 796(1-2), 296-298 (1998).
162. Yang SH, Liu R, Wen Y et al.: Neuroendocrine mechanism for tolerance to cerebral ischemia-reperfusion injury in male rats. J. Neurobiol. 62(3), 341-351 (2005).
163. Pan Y, Zhang H, Acharya AB, Patrick PH, Oliver D, Morley JE: Effect of testosterone on functional recovery in a castrate male rat stroke model. Brain Res. 1043(1-2), 195-204 (2005).
164. Traish AM, Kypreos KE: Testosterone and cardiovascular disease: an old idea with modern clinical implications. Atherosclerosis 214(2), 244-248 (2011).
165. Page ST, Amory JK, Bowman FD et al.: Exogenous testosterone (t) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum t. J. Clin. Endocrinol. Metab. 90(3), 1502-1510 (2005).
166. Basaria S, Coviello AD, Travison TG et al.: Adverse events associated with testosterone administration. N. Engl. J. Med. 363(2), 109-122 (2010).
167. Olsen TS, Andersen KK: Female survival advantage relates to male inferiority rather than female superiority: a hypothesis based on the impact of age and stroke severity on 1-week to 1-year case fatality in 40,155 men and women. Gend. Med. 7(4), 284-295 (2010). Emphasizes the role of testosterone in sex differences in stroke.
168. Agirbasli M, Agaoglu NB, Orak N et al.: Sex hormones, insulin resistance and high-density lipoprotein cholesterol levels in children. Horm. Res. Paediatr. 73(3), 166-174 (2010).
169. Sekido R, Lovell-Badge R: Sex determination involves synergistic action of sry and sf1 on a specific sox9 enhancer. Nature 453(7197), 930-934 (2008).
170. Dewing P, Chiang CW, Sinchak K et al.: Direct regulation of adult brain function by the male-specific factor sry. Curr. Biol. 16(4), 415-420 (2006).
171. De Vries GJ: Minireview: sex differences in adult and developing brains: compensation, compensation, compensation. Endocrinology 145(3), 1063-1068 (2004).
172. Ngun TC, Ghahramani N, Sanchez FJ, Bocklandt S, Vilain E: The genetics of sex differences in brain and behaviour. Front. Neuroendocrinol. (2010) (Epub ahead of print). Good review on sex differences in the brain.
173. Carrel L, Willard HF: X-inactivation profile reveals extensive variability in x-linked gene expression in females. Nature 434(7031), 400-404 (2005).
174. Carrel L, Cottle AA, Goglin KC, Willard HF: A first-generation x-inactivation profile of the human x chromosome. Proc. Natl Acad. Sci. USA 96(25), 14440-14444 (1999).
175. Disteche CM: Escape from x inactivation in human and mouse. Trends Genet. 11(1), 17-22 (1995).
176. Escapees on the X chromosome. Proc. Natl Acad. Sci. USA 96(25), 14180-14182 (1999).
177. Erwin JA, Lee JT: New twists in x-chromosome inactivation. Curr. Opin. Cell Biol. 20(3), 349-355 (2008).
178. Brown S, Rastan S: Age-related reactivation of an x-linked gene close to the inactivation centre in the mouse. Genet. Res. 52(2), 151-154 (1988).
179. Wareham KA, Lyon MF, Glenister PH, Williams ED: Age related reactivation of an x-linked gene. Nature 327(6124), 725-727 (1987).
180. Davies W, Genomic imprinting on the X chromosome: implications for brain and behavioral phenotypes. Ann. NY Acad. Sci. (Suppl. 1204), E14-E19 (2010).
181. Gregg C, Zhang J, Butler JE, Haig D, Dulac C: Sex-specific parent-of-origin allelic expression in the mouse brain. Science 329(5992), 682-685 (2010).
182. Lockshin MD: Nonhormonal explanations for sex discrepancy in human illness. Ann. NY Acad. Sci. 1193, 22-24 (2010).
183. Payer B, Lee JT: X chromosome dosage compensation: how mammals keep the balance. Annu. Rev. Genet. 42, 733-772 (2008).
184. Skaletsky H, Kuroda-Kawaguchi T, Minx PJ et al.: The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes. Nature 423(6942), 825-837 (2003).
185. Sekido R, Lovell-Badge R: Sex determination and sry: down to a wink and a nudge? Trends Genet. 25(1), 19-29 (2009).
186. Teuscher C, Noubade R, Spach K et al.: Evidence that the Y chromosome influences autoimmune disease in male and female mice. Proc. Natl Acad. Sci. USA 103(21), 8024-8029 (2006).
187. Arnold AP: Mouse models for evaluating sex chromosome effects that cause sex differences in non-gonadal tissues. J. Neuroendocrinol. 21(4), 377-386 (2009).
188. Arnold AP, Chen X: What does the "four core genotypes" mouse model tell us about sex differences in the brain and other tissues? Front. Neuroendocrinol. 30(1), 1-9 (2009).
189. Smith-Bouvier DL, Divekar AA, Sasidhar M et al.: A role for sex chromosome complement in the female bias in autoimmune disease. J. Exp. Med. 205(5), 1099-1108 (2008).
190. Gioiosa L, Chen X, Watkins R et al.: Sex chromosome complement affects nociception in tests of acute and chronic exposure to morphine in mice. Horm. Behav. 53(1), 124-130 (2008).
191. Rodenhiser D, Mann M: Epigenetics and human disease: translating basic biology into clinical applications. CMAJ 174(3), 341-348 (2006).
192. Hassig CA, Schreiber SL: Nuclear histone acetylases and deacetylases and transcriptional regulation: hats off to HDACs. Curr. Opin. Chem. Biol. 1(3), 300-308 (1997).
193. Okamoto I, Otte AP, Allis CD, Reinberg D, Heard E: Epigenetic dynamics of imprinted X inactivation during early mouse development. Science 303(5658), 644-649 (2004).
194. Csankovszki G, Nagy A, Jaenisch R: Synergism of xist RNA, DNA methylation, and histone hypoacetylation in maintaining X chromosome inactivation. J. Cell Biol. 153(4), 773-784 (2001).
195. Qureshi IA, Mehler MF: Emerging role of epigenetics in stroke: part 1: DNA methylation and chromatin modifications. Arch. Neurol. 67(11), 1316-1322 (2010).
196. Tsai HW, Grant PA, Rissman EF: Sex differences in histone modifications in the neonatal mouse brain. Epigenetics 4(1), 47-53 (2009).
197. Leader JE, Wang C, Fu M, Pestell RG: Epigenetic regulation of nuclear steroid receptors. Biochem. Pharmacol. 72(11), 1589-1596 (2006).
198. Wilson ME, Westberry JM: Regulation of oestrogen receptor gene expression: new insights and novel mechanisms. J. Neuroendocrinol. 21(4), 238-242 (2009).
199. Wilson ME, Westberry JM, Trout AL: Estrogen receptor-α gene expression in the cortex: sex differences during development and in adulthood. Horm. Behav. 59(3), 353-357 (2011).
200. Westberry JM, Trout AL, Wilson ME: Epigenetic regulation of estrogen receptor α gene expression in the mouse cortex during early postnatal development. Endocrinology 151(2), 731-740 (2010).
201. Dubal DB, Rau SW, Shughrue PJ et al.: Differential modulation of estrogen receptors (ERs) in ischemic brain injury: a role for ERα in estradiol-mediated protection against delayed cell death. Endocrinology 147(6), 3076-3084 (2006).
202. Dubal DB, Shughrue PJ, Wilson ME, Merchenthaler I, Wise PM: Estradiol modulates Bcl-2 in cerebral ischemia: a potential role for estrogen receptors. J. Neurosci. 19(15), 6385-6393 (1999).
203. Westberry JM, Prewitt AK, Wilson ME: Epigenetic regulation of the estrogen receptor α promoter in the cerebral cortex following ischemia in male and female rats. Neuroscience 152(4), 982-989 (2008).
204. Sohrabji F, Miranda RC, Toran-Allerand CD: Identification of a putative estrogen response element in the gene encoding brain-derived neurotrophic factor. Proc. Natl Acad. Sci. USA 92(24), 11110-11114 (1995).
205. McCarthy MM, Auger AP, Bale TL et al.: The epigenetics of sex differences in the brain. J. Neurosci. 29(41), 12815-12823 (2009). Good review on epigenetics and sex differences in the brain.
206. O'Keefe JA, Li Y, Burgess LH, Handa RJ: Estrogen receptor mRNA alterations in the developing rat hippocampus. Brain Res. Mol. Brain Res. 30(1), 115-124 (1995).
207. Prewitt AK, Wilson ME: Changes in estrogen receptor-α mRNA in the mouse cortex during development. Brain Res. 1134(1), 62-69 (2007).
208. Rainbow TC, Parsons B, McEwen BS: Sex differences in rat brain oestrogen and progestin receptors. Nature 300(5893), 648-649 (1982).
209. Kurian JR, Olesen KM, Auger AP: Sex differences in epigenetic regulation of the estrogen receptor-α promoter within the developing preoptic area. Endocrinology 151(5), 2297-2305 (2010).
210. DonCarlos LL, McAbee M, Ramer-Quinn DS, Stancik DM: Estrogen receptor mRNA levels in the preoptic area of neonatal rats are responsive to hormone manipulation. Brain Res. Dev. Brain Res. 84(2), 253-260 (1995).
211. Yokosuka M, Okamura H, Hayashi S: Postnatal development and sex difference in neurons containing estrogen receptor-α immunoreactivity in the preoptic brain, the diencephalon, and the amygdala in the rat. J. Comp. Neurol. 389(1), 81-93 (1997).
212. Brown TJ, Hochberg RB, Zielinski JE, MacLusky NJ: Regional sex differences in cell nuclear estrogen-binding capacity in the rat hypothalamus and preoptic area. Endocrinology 123(4), 1761-1770 (1988).
213. Lauber AH, Mobbs CV, Muramatsu M, Pfaff DW: Estrogen receptor messenger rna expression in rat hypothalamus as a function of genetic sex and estrogen dose. Endocrinology 129(6), 3180-3186 (1991).
214. Maerkel K, Durrer S, Henseler M, Schlumpf M, Lichtensteiger W: Sexually dimorphic gene regulation in brain as a target for endocrine disrupters: developmental exposure of rats to 4-methylbenzylidene camphor. Toxicol. Appl. Pharmacol. 218(2), 152-165 (2007).
215. Ogawa S, Taylor JA, Lubahn DB, Korach KS, Pfaff DW: Reversal of sex roles in genetic female mice by disruption of estrogen receptor gene. Neuroendocrinology 64(6), 467-470 (1996).
216. Touze E, Rothwell PM: Sex differences in heritability of ischemic stroke: a systematic review and meta-analysis. Stroke 39(1), 16-23 (2008).
217. Weaver IC, Cervoni N, Champagne FA et al.: Epigenetic programming by maternal behaviour. Nat. Neurosci. 7(8), 847-854 (2004).
218. Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K, Clark PM: Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome x): relation to reduced fetal growth. Diabetologia 36(1), 62-67 (1993).
219. Suzuki S, Gerhold LM, Bottner M et al.: Estradiol enhances neurogenesis following ischemic stroke through estrogen receptors α and b. J. Comp. Neurol. 500(6), 1064-1075 (2007).
220. US Census Bureau www.census.gov/apsd/wepeople/we-9.pdf (Accessed 18 February 2011)